| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |